Carcinotech
My visitor profile
Carcinotech
Description of your activity
- 3D printed human tumours for drug screening and diagnostics
More information
- Carcinotech is revolutionising cancer research by manufacturing 3D-printed micro-tumours using patient-derived biopsies, primary cells, immune cells, and cancer stem cells. Our advanced offering provides a platform for rapid, ethical, and accurate drug screening, pre-clinical, and personalised medicine testing. Carcinotech’s goal is to accelerate drug screening and enable the delivery of more effective cancer treatments to market. Using patient biopsies, tissue engineering, advanced robotic manufacturing, and quality control to produce highly predictive, assay-ready printed tumours at significant throughput. This provides our clients with a “clinical biopsy” quality model, using isolated patient-specific cells and representing donor-specific cancer heterogeneity. Our vision is to be at the forefront of cancer drug testing and provide personalised medicine testing to each individual suffering from cancer to better their chance of treatment and survival. Working with global partners, leading pharma companies, surgeons, pathologists, and clinicians Carcinotech is changing the face of oncology drug development by working to make this vision a reality.
Social Networks
Emerging company
Ishani MALHOTRA
CEO
Date of your company creation:
- Between 3 & 5 years
Main sector
- Medical device or technology
Address
- Country : UNITED KINGDOM
- City : Edinburgh
- Zip Code : EH25 9RG
Participation objectives
Partnering objectives
- Network development, Customer development
Description of my participation objective
- Partners and collaborators in validation of our 3D printed human tumours as a pre-clinical drug discovery model across multiple oncology therapies and strategies.